Literature DB >> 3591614

Torsades de pointes associated with drugs and toxins: recognition and management.

H G Stratmann, H L Kennedy.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3591614     DOI： 10.1016/0002-8703(87)90664-8

Source DB:  PubMed          Journal:  Am Heart J        ISSN： 0002-8703            Impact factor:   4.749


× No keyword cloud information.
  16 in total

Review 1.  Dofetilide: a review of its use in atrial fibrillation and atrial flutter.

Authors:  K J McClellan; A Markham
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  Knowledge deficits related to the QT interval could affect patient safety.

Authors:  Nancy M Allen LaPointe; Sana M Al-Khatib; Judith M Kramer; Robert M Califf
Journal:  Ann Noninvasive Electrocardiol       Date:  2003-04       Impact factor: 1.468

3.  Torsades de pointe with flecainide-amiodarone therapy.

Authors:  P Andrivet; V Beaslay; V D Canh
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

Review 4.  Drugs, QT interval prolongation and ICH E14: the need to get it right.

Authors:  Rashmi R Shah
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 5.  Update on the evaluation of a new drug for effects on cardiac repolarization in humans: issues in early drug development.

Authors:  Vaibhav Salvi; Dilip R Karnad; Gopi Krishna Panicker; Snehal Kothari
Journal:  Br J Pharmacol       Date:  2009-09-23       Impact factor: 8.739

6.  Electrophysiologic mechanisms of ventricular arrhythmias.

Authors:  N el-Sherif
Journal:  Int J Card Imaging       Date:  1991

Review 7.  Pharmacological treatment of acquired QT prolongation and torsades de pointes.

Authors:  Simon H L Thomas; Elijah R Behr
Journal:  Br J Clin Pharmacol       Date:  2015-10-26       Impact factor: 4.335

8.  Effects of cromakalim or glibenclamide on arrhythmias and dispersion of refractoriness in chronically infarcted in anesthetized dogs.

Authors:  A J D'Alonzo; J C Sewter; R B Darbenzio; T A Hess
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-08       Impact factor: 3.000

Review 9.  Possible risk for cardiac arrhythmia related to intravenous erythromycin.

Authors:  W E Haefeli; R A Schoenenberger; P Weiss; R Ritz
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

Review 10.  Torsades de pointes: prevention and therapy.

Authors:  A Keren; D Tzivoni
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.